Track topics on Twitter Track topics that are important to you
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181231005036/en/
Technavio predicts the global continuous renal replacement therapy devices market to post a CAGR of more than 7% by 2022. (Graphic: Business Wire)
A key driver for the global continuous renal replacement therapy devices market will be the advantages of CRRT over IRRT. CRRT provides some major clinical advantages such as more hemodynamic stability, adequate fluid removal, better recovery of renal function, and more efficient removal of small and large metabolites when compared with IRRT. Medical practitioners prefer CRRT as the method for dialysis due to these advantages, which is driving the market demand for CRRT.
This global continuous renal replacement therapy devices marketresearchreportalso provides an analysis of the most important trends expected to impact the market outlook during the period 2018-2022. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the focus on miniaturization of wearable technology for infant and pediatric applications as one of the key trends in the global continuous renal replacement therapy devices market:
Global continuous renal replacement therapy devices market: Focus on miniaturization of wearable technology for infant and pediatric applications
In the future, there is great scope for the application of nanotechnology, microfluidics, and other emerging sciences in the field of renal replacement. The wearable systems for ultrafiltration are also being tested to determine their effectiveness. In the wearable devices market, off-the-shelf components are generally used. But, developments in terms of creating new designs and applying newly conceived and dedicated technology are being witnessed in the market.
“Wearable devices are usually used for ambulatory care and for treatment outside hospital settings. The miniaturized systems could be useful in providing better care to acutely ill patients that have difficulty in moving or who are bedridden when compared with the previously available treatments,” says a senior research analyst at Technavio.
Global continuous renal replacement therapy devices market: Segmentation analysis
This continuous renal replacement therapy devices market analysis report segments the market by modality (continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF)) and geography (the Americas, APAC, and EMEA).
The CVVH segment held the largest continuous renal replacement therapy devices market share in 2017, accounting for nearly 52% of the market. This segment is expected to dominate the global market throughout the forecast period.
The EMEA region led the market in 2017 with about 40% of the market share, followed by the Americas and APAC respectively. The EMEA region is expected to dominate the market throughout the period 2018-2022.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...
Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...